Sustained phosphorylation of STAT3 was related to a PD-L1 expression on CD44+ cells, enabling these cells to bypass immune surveillance, and providing mechanisms to maintain tumor quiescence making possible relapse after treatment. Here, STAT3 is linked to neoplasm.